Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/hepatitis-b-virus-reactivation-associated-with-anti-neoplastic-therapy-Ki6EkktYwx
References (87)
-
Y. Liaw, J. Kao, T. Piratvisuth, H. Chan, R. Chien, Chun-Jen Liu, E. Gane, S. Locarnini, S. Lim, K. Han, D. Amarapurkar, G. Cooksley, W. Jafri, R. Mohamed, J. Hou, W. Chuang, L. Lesmana, J. Sollano, D. Suh, M. Omata (2012)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 updateHepatology International, 6
-
R. Loomba, Ayana Rowley, R. Wesley, T. Liang, J. Hoofnagle, F. Pucino, G. Csako (2008)
Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during ChemotherapyAnnals of Internal Medicine, 148
-
O. Shibolet, Y. Ilan, S. Gillis, A. Hubert, D. Shouval, R. Safadi (2002)
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers.Blood, 100 2
-
G. Lau, H. Yiu, D. Fong, Hoi-Ching Cheng, W. Au, L. Lai, M. Cheung, Hai‐ying Zhang, A. Lie, R. Ngan, R. Liang (2003)
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.Gastroenterology, 125 6
-
S. Pei, M. Ma, Ming-Chung Wang, C. Kuo, Kun-Min Rau, Cheng-Yu Su, Chien-Hung Chen (2012)
Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapyAnnals of Hematology, 91
-
A. Cheng, C. Hsiung, I. Su, Pei‐Jer Chen, M. Chang, C. Tsao, Woei-Yao Kao, W. Uen, Chih-Hung Hsu, H. Tien, T. Chao, Li‐Tzong Chen, J. Whang‐Peng (2003)
Steroid‐free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV‐carriers with lymphomaHepatology, 37
-
H. Nagamatsu, R. Kumashiro, S. Itano, Satoru Matsugaki, M. Sata (2003)
Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC.Hepatology research : the official journal of the Japan Society of Hepatology, 26 4
-
C. Liao, Chuan‐Mo Lee, Hong-cheng Wu, Ming-Chung Wang, Sheng-Nan Lu, H. Eng (2002)
Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non‐Hodgkin's lymphomaBritish Journal of Haematology, 116
-
D. Ganem, A. Prince (2004)
Hepatitis B virus infection--natural history and clinical consequences.The New England journal of medicine, 350 11
-
M. Kris, P. Hesketh, J. Herrstedt, C. Rittenberg, L. Einhorn, S. Grunberg, J. Koeller, I. Olver, S. Borjeson, E. Ballatori (2005)
Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapySupportive Care in Cancer, 13
-
K. Kitano, Hikaru Kobayashi, Mayu Hanamura, K. Furuta, M. Ueno, A. Rokuhara, E. Tanaka, T. Umemura, K. Kiyosawa (2006)
Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor regionEuropean Journal of Haematology, 77
-
Guías Clínica (1971)
European Association for the Study of the LiverGut, 12
-
D. Ji, Junning Cao, X. Hong, Junmin Li, Jian-min Wang, Fangyuan Chen, Chun Wang, S. Zou (2010)
Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B‐cell lymphoma patients who are HBsAg‐negative/ HBcAb‐positive: a multicenter retrospective studyEuropean Journal of Haematology, 85
-
Lee (1997)
Hepatitis B infectionN. Engl. J. Med., 337
-
Lenna Martyak, Ehsan Taqavi, S. Saab (2007)
Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation‐related mortality in chemotherapy patients: a meta‐analysisLiver International, 28
-
N. Tsai, N. Gitlin (2010)
Chronic hepatitis B : an update -
D. Francisci, F. Falcinelli, E. Schiaroli, M. Capponi, B. Belfiori, L. Flenghi, F. Baldelli (2010)
Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with ChemotherapyInfection, 38
-
Chiun Hsu, C. Hsiung, I. Su, W. Hwang, Ming-Chung Wang, Sheng‐Fung Lin, T. Lin, H. Hsiao, Ji‐Hsiung Young, M. Chang, Y. Liao, C. Li, Hung-Bo Wu, H. Tien, T. Chao, T. Liu, A. Cheng, Pei‐Jer Chen (2008)
A revisit of prophylactic lamivudine for chemotherapy‐associated hepatitis B reactivation in non‐Hodgkin's lymphoma: A randomized trialHepatology, 47
-
N. Yuki, T. Nagaoka, M. Yamashiro, K. Mochizuki, A. Kaneko, Keiji Yamamoto, M. Omura, K. Hikiji, Michio Kato (2003)
Long‐term histologic and virologic outcomes of acute self‐limited hepatitis BHepatology, 37
-
L. Kwak, J. Halpern, R. Olshen, S. Horning (1990)
Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 8 6
-
G. Rossi, A. Pelizzari, M. Motta, M. Puoti (2001)
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapyBritish Journal of Haematology, 115
-
W. Yeo, T. Chan, N. Leung, W. Lam, F. Mo, M. Chu, H. Chan, E. Hui, K. Lei, T. Mok, P. Chan (2009)
Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 4
-
(1980)
Cytotoxic chemotherapyReactions, 6
-
National Comprehensive Cancer Network. NCCN Clincial Practice gudeleines in Oncology-Non-Hodgkin's lymphoma (Version 2.2012). 2012; 139. Cited -
Y. Oshima, H. Tsukamoto, A. Tojo (2013)
Association of hepatitis B with antirheumatic drugs: a case–control studyModern Rheumatology, 23
-
A. Lok, C. Lai, P. Wu, V. Wong, E. Yeoh, H. Lin (1987)
Hepatitis B virus infection in Chinese families in Hong Kong.American journal of epidemiology, 126 3
-
A. Evens, B. Jovanovic, Yu-Chieh Su, D. Raisch, D. Ganger, S. Belknap, M. Dai, B. Chiu, Bara Fintel, Yan-Wen Cheng, S. Chuang, M.-Y. Lee, T.-Y. Chen, S.-F. Lin, Cheng-Yu Kuo (2011)
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports.Annals of oncology : official journal of the European Society for Medical Oncology, 22 5
-
W. Yeo, W. Ho, P. Hui, C. Lam, B. Zee, W. Kwan, P. Chan, J. Lee, P. Johnson (2004)
Lamivudine for the prevention of hepatitis B virus reactivation in hbsag seropositive cancer patients undergoing cytotoxic chemotherapyEjc Supplements, 2
-
S. Saab, M. Dong, T. Joseph, M. Tong (2007)
Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: A decision analysis modelHepatology, 46
-
J. Hoofnagle, G. Davis, S. Pappas, R. Hanson, M. Peters, M. Avigan, J. Waggoner, E. Jones, L. Seeff (2020)
A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.Annals of internal medicine, 104 1
-
W. Yeo, F. Mo, S. Chan, N. Leung, P. Hui, W. Lam, T. Mok, Kowk Lam, W. Ho, J. Koh, Julian Tang, A. Chan, P. Chan (2007)
Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapyHepatology, 45
-
P. Borentain, P. Colson, D. Coso, E. Bories, A. Charbonnier, A. Stoppa, T. Auran, A. Loundou, A. Motte, E. Ressiot, E. Norguet, C. Chabannon, R. Bouabdallah, C. Tamalet, R. Gérolami (2010)
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg‐negative and anti‐HBc antibodies‐positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancerJournal of Viral Hepatitis, 17
-
U. Lazdina, M. Alheim, J. Nyström, C. Hultgren, Gallina Borisova, I. Sominskaya, P. Pumpens, D. Peterson, D. Milich, M. Sällberg (2003)
Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent.The Journal of general virology, 84 Pt 1
-
D. Bedognetti, G. Zoppoli, M. Sertoli, E. Zanardi, Pietro Blandini, Lorenzo Uccellini, F. Boccardo, G. Andreoli, R. Ghio, O. Racchi, M. Ferrarini, A. Maria (2010)
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab eraInternational Journal of Hematology, 91
-
S. Leaw, C. Yen, Wen‐Tsung Huang, Tsai-Yun Chen, W. Su, C. Tsao (2004)
Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapyAnnals of Hematology, 83
-
B. Rehermann, C. Ferrari, C. Pasquinelli, F. Chisari (1996)
The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte responseNature Medicine, 2
-
Wang Wang, Fan Fan, Sun Sun, Hou Hou
Prevention and management of drug resistant HBV infectionJ. Gastroenterol. Hepatol., 27
-
Y. Koo, Daniel Tan, I. Tan, M. Tao, W. Chow, S. Lim (2009)
Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapyCancer, 116
-
U. Zurawska, L. Hicks, G. Woo, C. Bell, M. Krahn, Kelvin Chan, J. Feld (2012)
Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 26
-
W. Yeo, P. Chan, P. Hui, W. Ho, K. Lam, W. Kwan, S. Zhong, P. Johnson (2003)
Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective studyJournal of Medical Virology, 70
-
W. Yeo, P. Chan, H. Chan, F. Mo, P. Johnson (2001)
Hepatitis B virus reactivation during cytotoxic chemotherapy‐enhanced viral replication precedes overt hepatitisJournal of Medical Virology, 65
-
Cheng Wang, R. Fan, Jian Sun, J. Hou (2012)
Prevention and management of drug resistant hepatitis B virus infectionsJournal of Gastroenterology and Hepatology, 27
-
N. Fukushima, T. Mizuta, Mariko Tanaka, M. Yokoo, Masaru Ide, Takashi Hisatomi, N. Kuwahara, R. Tomimasu, N. Tsuneyoshi, N. Funai, E. Sueoka (2009)
Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier.Annals of oncology : official journal of the European Society for Medical Oncology, 20 12
-
A. Österborg, M. Dyer, D. Bunjes, G. Pangalis, Y. Bastion, D. Catovsky, H. Mellstedt (1997)
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 4
-
Oshima (2012)
Association of hepatitis B with antirheumatic drugs: a case-control studyMod. Rheumatol.
-
J. Gisbert, M. Chaparro, M. Esteve (2011)
Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 33
-
A. Lok, P. Wu, Ching. Lai, J. Lau, E. Leung, L. Wong, O. Ma, I. Lauder, Clara Ng, H. Chung (1992)
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B.Gastroenterology, 102 6
-
(2012)
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.Journal of hepatology, 57 1
-
M. Citron, D. Berry, C. Cirrincione, C. Hudis, E. Winer, W. Gradishar, N. Davidson, S. Martino, R. Livingston, J. Ingle, E. Perez, J. Carpenter, D. Hurd, J. Holland, Barbara Smith, Carolyn Sartor, Eleanor Leung, J. Abrams, R. Schilsky, H. Muss, L. Norton (2003)
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 8
-
A. Cheng (1996)
Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.Blood, 87 3
-
K. Kumagai, T. Takagi, Shigeo Nakamura, U. Sawada, Y. Kura, F. Kodama, S. Shimano, I. Kudoh, H. Nakamura, Ken-ichi Sawada, T. Ohnoshi (1997)
Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan.Annals of oncology : official journal of the European Society for Medical Oncology, 8 Suppl 1
-
I. Lund, A. Skulberg, I. Helle (1974)
Letter: Occupational hazard of halothane.Lancet, 2 7879
-
Xunrong Luo, Au Yan, R. Liang, G. Lau (2001)
Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy — pathogenesis and managementReviews in Medical Virology, 11
-
B. Koblin, P. Taylor, C. Stevens (1998)
Hepatitis B virus infection.The New England journal of medicine, 338 18
-
J. Jang, J. Kwon, C. You, Jin Kim, H. Woo, S. Bae, J. Choi, S. Yoon, K. Chung (2011)
Risk of HBV Reactivation According to Viral Status and Treatment Intensity in Patients with Hepatocellular CarcinomaAntiviral Therapy, 16
-
N. Cooper, D. Arnold (2010)
The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseasesBritish Journal of Haematology, 149
-
M. Dai, Pei-Fen Wu, Jang-Jih Lu, R. Shyu, T. Chao (2004)
Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal follow-upSupportive Care in Cancer, 12
-
A. Hanbali, Y. Khaled (2009)
Incidence of hepatitis B reactivation following Rituximab therapyAmerican Journal of Hematology, 84
-
Yeo (2004)
Lamivudine for the prevention of hepatitis B virus reactivation in HBsAg seropositive cancer patients undergoing cytotoxic chemotherapyJ. Clin. Oncol., 15
-
G. Gores (2009)
HEPATOLOGY: A home for hepatocellular cancer publicationsHepatology, 50
-
F. Suzan, M. Ammor, V. Ribrag (2001)
Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.The New England journal of medicine, 345 13
-
N. Leung, J. Tam, G. Lau, T. Leung, W. Lau, A. Li (1994)
Hepatitis B virus DNA in peripheral blood leukocytes. A comparison between hepatocellular carcinoma and other hepatitis B virus‐related chronic liver diseasesCancer, 73
-
S. Goyama, Y. Kanda, Y. Nannya, Masahito Kawazu, M. Takeshita, M. Niino, Y. Komeno, T. Nakamoto, M. Kurokawa, S. Tsujino, S. Ogawa, K. Aoki, S. Chiba, T. Motokura, Y. Shiratori, H. Hirai (2002)
Reverse Seroconversion of Hepatitis B Virus after Hematopoietic Stem Cell TransplantationLeukemia & Lymphoma, 43
-
K. Matsue, S. Kimura, Yoko Takanashi, Kan-ichi Iwama, Hideaki Fujiwara, M. Yamakura, M. Takeuchi (2010)
Reactivation of hepatitis B virus after rituximab‐containing treatment in patients with CD20‐positive B‐cell lymphomaCancer, 116
-
C. Targhetta, M. Cabras, A. Mamusa, G. Mascia, E. Angelucci (2008)
Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapyHaematologica, 93
-
G. Lau, Y. Leung, D. Fong, W. Au, Y. Kwong, A. Lie, J. Hou, Y. Wen, Amin Nanj, R. Liang (2002)
High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation.Blood, 99 7
-
R. Liang, R. Liang, A. Lok, Ching. Lai, T. Chan, D. Todd, E. Chiu (1990)
Hepatitis B infection in patients with lymphomasHematological Oncology, 8
-
Y. Nakamura, T. Motokura, A. Fujita, T. Yamashita, E. Ogata (1996)
Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies: Survey in Japan, 1987‐1991Cancer, 78
-
Raymond Liang, George Lau, Y. Kwong (1999)
Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 1
-
A. Lok, R. Liang, E. Chiu, K. Wong, T. Chan, D. Todd (1991)
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.Gastroenterology, 100
-
R. Galbraith, Roger Williams, A. Eddleston, A. Zuckerman, K. Bagshawe (1975)
FULMINANT HEPATIC FAILURE IN LEUKAEMIA AND CHORIOCARCINOMA RELATED TO WITHDRAWAL OF CYTOTOXIC DRUG THERAPYThe Lancet, 306
-
W. Yeo, P. Johnson (2006)
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapyHepatology, 43
-
V. Vita, S. Hubbard, D. Longo (1987)
The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.Cancer research, 47 22
-
A. Lok, B. McMahon (2009)
Chronic hepatitis B: Update 2009Hepatology, 50
-
F. Clark, M. Drummond, S. Chambers, B. Chapman, W. Patton (1998)
Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma.Annals of oncology : official journal of the European Society for Medical Oncology, 9 4
-
W. Yeo, P. Chan, S. Zhong, W. Ho, J. Steinberg, J. Tam, P. Hui, N. Leung, B. Zee, P. Johnson (2000)
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factorsJournal of Medical Virology, 62
-
M. Dai, Pei-Fen Wu, Jang-Jih Lu, R. Shyu, T. Chao (2004)
Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 12 3
-
G. Bonadonna, P. Valagussa, A. Moliterni, M. Zambetti, C. Brambilla (1995)
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.The New England journal of medicine, 332 14
-
F. Borg, Suzanne Smorenburg, R. Man, R. Rietbroek, R. Chamuleau, E. Jones (1998)
Case Report: Recovery from Life-Threatening, Corticosteroid-Unresponsive, Chemotherapy-Related Reactivation of Hepatitis B Associated with Lamivudine TherapyDigestive Diseases and Sciences, 43
-
A. Webster, M. Brenner, H. Prentice, P. Griffiths (1989)
Fatal hepatitis B reactivation after autologous bone marrow transplantation.Bone marrow transplantation, 4 2
-
W. Yeo, T. Mok, B. Zee, T. Leung, P. Lai, W. Lau, J. Koh, F. Mo, Simon Yu, A. Chan, P. Hui, B. Ma, K. Lam, W. Ho, H. Wong, A. Tang, P. Johnson (2005)
A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.Journal of the National Cancer Institute, 97 20
-
C. Hui, W. Cheung, Hai‐ying Zhang, W. Au, Yui-hung Yueng, A. Leung, N. Leung, J. Luk, A. Lie, Y. Kwong, R. Liang, G. Lau (2006)
Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.Gastroenterology, 131 1
-
George Lau, Cheuk-Kwong Lee, Raymond Liang (1999)
Hepatitis B virus infection and bone marrow transplantation.Critical reviews in oncology/hematology, 31 1
-
J. Wands, C. Chura, F. Roll, W. Maddrey (1975)
Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders.Gastroenterology, 68 1
-
W. Yeo, K. Lam, B. Zee, P. Chan, F. Mo, W. Ho, W. Wong, T. Leung, A. Chan, B. Ma, T. Mok, P. Johnson (2004)
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.Annals of oncology : official journal of the European Society for Medical Oncology, 15 11
-
G. Lau, M. He, D. Fong, A. Bartholomeusz, W. Au, A. Lie, S. Locarnini, R. Liang (2002)
Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantationHepatology, 36
-
A. Rattan, A. Tehlan (1989)
Hepatitis B infection.Indian pediatrics, 26 1
- Publisher
- Wiley
- Copyright
- Copyright © 2013 Wiley Publishing Asia Pty Ltd and Journal of Gastroenterology and Hepatology Foundation
- ISSN
- 0815-9319
- eISSN
- 1440-1746
- DOI
- 10.1111/j.1440-1746.2012.07280.x
- pmid
- 23020594
- Publisher site
- See Article on Publisher Site
Abstract
Reactivation of hepatitis B virus (HBV) infection is a known complication during and after anti‐cancer therapy. This condition can affect two patient populations: it is most commonly seen in patients who are seropositive for hepatitis B surface antigen (HBsAg), but it is also being increasingly reported among patients who are HBsAg‐negative but who have prior infection, as evident by seropositive status for antibody to hepatitis B core antigen (anti‐HBc), irrespective of their anti‐HBs (antibody to HBsAg) status. The clinical course can vary from asymptomatic hepatitis to fulminant hepatic failure that can be potentially fatal. With the increasing use of biological agents in addition to potent cytotoxic chemotherapy in the armamentarium of anti‐cancer treatments, reactivation of hepatitis B has become a common clinical situation that is faced by both oncologists and hepatologists especially in HBV endemic areas. In this review, we discuss the clinical course of reactivation in the two HBV‐infected sub‐populations, and the role of anti‐virals in the prevention and management of HBV reactivation in association with cytotoxic chemotherapy and biological therapies.
Journal
Journal of Gastroenterology and Hepatology – Wiley
Published: Jan 1, 2013